Pathogenese des systemischen Lupus erythematodes

M. Schiller; H.-M. Lorenz

doi:10.1055/s-0037-1618075

Arthritis und Rheuma, Table of Contents

Arthritis und Rheuma 2011; 31(04): 229-232
DOI: 10.1055/s-0037-1618075

Systemischer Lupus erythematodes

Schattauer GmbH

Pathogenese des systemischen Lupus erythematodes

Pathogenesis of systemic lupus erythematosus

M. Schiller

¹Medizinische Klinik V, Sektion Rheumatologie, Universität Heidelberg

,

H.-M. Lorenz

¹Medizinische Klinik V, Sektion Rheumatologie, Universität Heidelberg

› Author Affiliations

Abstract

Zusammenfassung

Der systemische Lupus erythematodes (SLE) ist eine Autoimmunerkrankung, die durch eine Vielzahl klinischer Manifestationen und die Beteiligung verschiedener Organe gekennzeichnet ist. Charakteristisch ist das Auftreten von Antikörpern gegen nukleäre Antigene. Die Ablagerung von Immunkomplexen und die Aktivierung des Komplementsystems führen schließlich zur systemischen Inflammation und zur Schädigung verschiedenster Organsysteme. Letztendlich sind die dieser systemisch entzündlichen Autoimmunerkrankung zugrunde liegenden Mechanismen bis heute nur teilweise verstanden. Zentral an der Pathogenese des SLE beteiligt scheinen jedoch eine Fehlregulation des apoptotischen Zelltodes bzw. eine Störung in der nichtentzündlichen Beseitigung apoptotischer Zellen durch professionelle Phagozyten. Nukleäre Autoantigene akkumulieren im Zytoplasma apoptotischer Zellen oder werden sogar auf deren Oberfläche exprimiert. Somit kommen apoptotische Zellen als Quelle der Autoantigene in Frage, gegen die sich die Autoimmunantwort bei SLE-Patienten richtet. Schließlich wurde erst kürzlich auch subzellulären Partikeln, die von apoptotischen Zellen freigesetzt werden und ebenfalls verschiedenste Autoantigene beinhalten, eine Rolle in der Pathogenese des SLE zugesprochen. Der vorliegende Beitrag soll neue Erkenntnisse zur SLE-Pathogenese zusammengefasst darstellen.

Summary

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by a variety of clinical manifestations involving various organ systems. A characteristic of SLE is the occurrence of autoantibodies against nuclear antigens. Deposition of immune complexes and activation of the complement system finally causes damage to different organ systems. However, the molecular mechanisms underlying this systemic inflammatory autoimmune disease are only partially understood to date. A dysregulation of apoptosis and the non-inflammatory phagocytic clearance of apoptotic cells is discussed as a central pathogenic mechanism in SLE. Nuclear autoantigens accumulate in the cytoplasm of apoptotic cells or are even exposed on their surface. Thus, apoptotic cells in fact represent a source of the antigens, which are targeted in an autoimmune reaction in SLE patients. Finally subcellular particles which contain a variety of autoantigens and released from apoptotic cells have been discussed to be involved in SLE pathogenesis. In this article recent findings on the pathogenesis of SLE are summarized.

Schlüsselwörter

Systemischer Lupus erythematodes - Apoptose - Immunkomplexe - Mikropartikel - Interferon Typ I

Keywords

Systemic lupus erythematosus - apoptosis - immune complexes - microparticles - type I interferon

Full Text

References

Literatur
1 Swaak AJ, Huysen V, Nossent JC, Smeenk RJ. Anti-nuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus. Clin Rheumatol 1990; 9 (01) (Suppl. 01) 82-94.
2 Munoz LE, Lauber K, Schiller M. et al. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 2010; 6 (05) 280-289.
3 Lorenz HM, Grunke M, Hieronymus T. et al. Hyporesponsiveness to gammac-chain cytokines in activated lymphocytes from patients with systemic lupus erythematosus leads to accelerated apoptosis. Eur J Immunol 2002; 32 (05) 1253-1263.
4 Baumann I, Kolowos W, Voll RE. et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002; 46 (01) 191-201.
5 Voll RE, Herrmann M, Roth EA. et al. Immunosuppressive effects of apoptotic cells. Nature 1997; 390 (6658) 350-351.
6 Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements; the tart cell and the L.E. cell. Mayo Clin Proc 1948; 23 (02) 25-28.
7 Hargraves MM. Production in vitro of the L.E. cell phenomenon; use of normal bone marrow elements and blood plasma from patients with acute disseminated lupus erythematosus. Mayo Clin Proc 1949; 24 (09) 234-237.
8 Courtney PA, Crockard AD, Williamson K. et al. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999; 58 (05) 309-314.
9 Gabler C, Blank N, Hieronymus T. et al. Extra-nuclear detection of histones and nucleosomes in activated human lymphoblasts as an early event in apoptosis. Ann Rheum Dis 2004; 63 (09) 1135-1144.
10 Radic M, Marion T, Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 2004; 172 (11) 6692-6700.
11 Casciola-Rosen L, Andrade F, Ulanet D. et al. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999; 190 (06) 815-826.
12 Bondanza A, Zimmermann VS, Dell'Antonio G. et al. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum 2004; 50 (05) 1549-1560.
13 Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006; 440 (7085) 808-812.
14 Pan ZJ, Maier S, Schwarz K. et al. Toll-like receptor 7 (TLR7) modulates anti-nucleosomal autoantibody isotype and renal complement deposition in mice exposed to syngeneic late apoptotic cells. Ann Rheum Dis 2010; 69 (06) 1195-1199.
15 Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418 (6894) 191-195.
16 Urbonaviciute V, Furnrohr BG, Meister S. et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008; 205 (13) 3007-3018.
17 Ma CY, Jiao YL, Zhang J. et al. Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol Int. 2010 Dec 1.
18 Ytterberg SR, Schnitzer TJ. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 1982; 25 (04) 401-406.
19 Baechler EC, Batliwalla FM, Karypis G. et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100 (05) 2610-2615.
20 Bauer JW, Petri M, Batliwalla FM. et al. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study. Arthritis Rheum 2009; 60 (10) 3098-3107.
21 Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008; 8 (08) 594-606.
22 Lovgren T, Eloranta ML, Bave U. et al. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 2004; 50 (06) 1861-1872.
23 Vermi W, Lonardi S, Morassi M. et al. Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage. Immunobiology 2009; 214 (9–10) 877-886.
24 Guiducci C, Gong M, Xu Z. et al. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 2010; 465 (7300) 937-941.
25 Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9 (08) 581-593.
26 Sebbagh M, Hamelin J, Bertoglio J. et al. Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner. J Exp Med 2005; 201 (03) 465-471.
27 Coleman ML, Sahai EA, Yeo M. et al. Membrane blebbing during apoptosis results from caspasemediated activation of ROCK I. Nat Cell Biol 2001; 3 (04) 339-345.
28 Beyer C, Pisetsky DS. The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol 2010; 6 (01) 21-29.
29 Schiller M, Bekeredjian-Ding I, Heyder P. et al. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ 2008; 15 (01) 183-191.
30 Heyder P, Bekeredjian-Ding I, Parcina M. et al. Purified apoptotic bodies stimulate plasmacytoid dendritic cells to produce IFN-alpha. Autoimmunity 2007; 40 (04) 331-332.
31 Fransen JH, Hilbrands LB, Jacobs CW. et al. Both early and late apoptotic blebs are taken up by DC and induce IL-6 production. Autoimmunity 2009; 42 (04) 325-327.
32 Fransen JH, Hilbrands LB, Ruben J. et al. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum 2009; 60 (08) 2304-2313.